GE HealthCare Technologies Inc. Common Stock vs Solaredge Technologies Inc — how do they compare? GE HealthCare Technologies Inc. Common Stock trades at $68.66 (market cap $31.07B), while Solaredge Technologies Inc trades at $29.98 (market cap $2.00B). The key difference: GE HealthCare Technologies Inc. Common Stock is far larger — about 15.5× Solaredge Technologies Inc's market cap, and GE HealthCare Technologies Inc. Common Stock pays a 0.23% dividend while Solaredge Technologies Inc pays none. Which is the better fit depends on your goals.
| GEHC | SEDG | |
|---|---|---|
Market Cap | $31.07B | $2.00B |
Volume | 3,443,020 | 2,563,287 |
Sector | Health | Energy |
52-Week High | $88.16 | $78.51 |
52-Week Low | $59.48 | $28.47 |
Enterprise Value | $39.53B | $1.86B |
Dividend Yield | 0.23% | — |
Typical Hold Time | — | 34 Days |
Signals from Pluang's Aura AI — not financial advice
GE HealthCare (GEHC) trades at $68.79, up 1.55% today, with a neutral technical signal. The company reported mixed quarterly earnings, beating in Q2 2026 but missing in Q1, and is set to announce Q3 results on October 28, 2026. Recent developments include a $945 million acquisition of SOFIE Biosciences to expand its PET radiopharmaceutical footprint, alongside ongoing securities fraud investigations noted in recent news.
The outlook is cautiously optimistic, supported by a strong analyst consensus with a $79.64 price target and no sell ratings. Key opportunities include growth from strategic acquisitions and AI innovations, while risks involve legal investigations, integration challenges from the SOFIE deal, and potential margin pressures from increased investing cash outflows in 2026.
SolarEdge Technologies (SEDG) trades at $30.52, down 3.05% on the day, as the stock faces bearish technical signals and ongoing financial challenges. The company reported a net loss of $405.45 million in 2025 despite revenue growth to $1.18 billion, with negative profit margins and declining cash flow trends. Recent news highlights multiple law firm investigations into investor claims, creating additional headwinds alongside sector-wide pressure from high borrowing costs affecting solar project financing.
The outlook remains challenging with bearish technical indicators and fundamental weaknesses, though analyst consensus suggests potential upside to $37.75. Key risks include ongoing financial losses, competitive pressures, and legal investigations, while opportunities exist in the company's AI data center initiatives and long-term revenue targets of $2.4 billion by 2029.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
GE HealthCare Technologies Inc. is a medical technology company, spun off from General Electric in 2023, that develops imaging systems, ultrasound devices, patient monitoring equipment, and diagnostic imaging agents. Its product lines include CT, MRI, and mammography systems alongside anesthesia delivery and maternal-infant care solutions.
Read more on GEHC →SolarEdge Technologies designs, develops, and sells direct current optimized inverter systems for solar photovoltaic installations. The company system consists of power optimizers, inverters, and cloud-based monitoring platform and addresses a broad range of solar market segments, from residential solar installations to commercial and small utility-scale solar installations. The company sells its products directly to solar installers, engineering, procurement, and construction firms and indirectly to solar installers through distributors and electrical equipment wholesalers. Additionally, the company has nonsolar products targeting energy storage and e-mobility.
Read more on SEDG →